Brevan Howard Capital Management LPBrevan Howard Capital Management LP

Institutional investor · Portfolio as of Q4 2016

SEC EDGAR SourceSEC Filings

Top Holdings2 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IBBIBB
ETF

ISHARES BIOTECHNOLOGY ETF

83,000$22M65.1%$92.98-7.14%
2 qtrssince 2016-Q3
Unchanged
0

CME GROUP INC

102,553$11.8M34.9%$64.90+25.52%
4 qtrssince 2016-Q1
Unchanged
0
$33.9M
AUM
2
Positions
Q4 2016
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'16
New0%Increased0%Decreased0%Exited100%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.0 quarters
<1Q0%1-4Q100%1-2Y0%2Y+0%

Brevan Howard Capital Management LP manages $33.9M across 2 positions as of Q4 2016. Top holdings: IBB (65.1%), CME (34.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2016 Summary

Active quarter - 0 new positions, 10 exits, 0 increased. No standout high-conviction moves this quarter. Portfolio: $34M across 2 positions.

Top holdings by portfolio weight

Total AUM$34M
IBB65.06%
CME34.94%
BHI0.00%
HAL0.00%
PBR0.00%
XME0.00%
SLB0.00%
VALE0.00%
GDX0.00%
FCX0.00%

Portfolio allocation by GICS sector

Sectors2
Unknown65.06%
Financial Services34.94%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction44
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
PRCTPRCTPROCEPT BIOROBOTICS CORP
Q3 2025 Q2 2026+61,661 shares+$1.1M
4Q
RKTRKTROCKET COS INC-CLASS A
Q3 2025 Q2 2026+1.1M shares+$17.7M
4Q
UGIUGIUGI CORP NEW
Q3 2025 Q2 2026+115,961 shares+$4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used